-+ 0.00%
-+ 0.00%
-+ 0.00%

Wells Fargo Maintains Equal-Weight on Integra Lifesciences, Raises Price Target to $15

Benzinga·05/06/2026 13:34:32
Listen to the news
Wells Fargo analyst Larry Biegelsen maintains Integra Lifesciences (NASDAQ:IART) with a Equal-Weight and raises the price target from $12 to $15.